ASX-LISTED digital medicines management company MedAdvisor has had its shares suspended from trading on the Australian Securities Exchange, pending the release of an announcement prior to the opening of trade next week.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Oct 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Oct 19
